Microgen PLC
25 March 2002
Microgen Selected as B2B e-Billing Service Provider to
customers of The Royal Bank of Scotland
Microgen, the UK's leading business-to-business ('B2B') e-Billing Service
Provider, and The Royal Bank of Scotland (RBS) today announced an agreement
under which Microgen will supply B2B e-Billing services to customers of RBS and
NatWest. Under the terms of the agreement the banks will promote Microgen to
their corporate customers as their recommended supplier of B2B e-billing
services.
With this agreement, RBS and NatWest are offering their customers a market-
leading and practical e-commerce solution that can help them achieve significant
business benefits, particularly in terms of cost-savings, cash-flow and their
own customer service. The arrangement brings together key players in the
process of issuing and settling invoices - supplier, service provider, customer
and bank.
Further information available at www.microgen.co.uk. or contact:
Mike Phillips, Group Finance Director, Microgen plc 01753-847123
Giles Sanderson, Financial Dynamics 0207 269 7100
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.